In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida families are feeling the squeeze as everyday costs, insurance premiums, and homeownership barriers continue to climb. House District 102 candidate Jayden D’Onofrio is calling for a broader, more unified affordability strategy—one that tackles the state’s insurance crisis, supports first‑time homebuyers, and restores real competition in the market. His message centers on transparency, practical solutions, and keeping Florida livable for the professionals, workers, and families who power its economy.
A decade of dramatic change is reshaping America’s health insurance markets. Employer group plans are becoming increasingly dominated by a few powerful insurers, while the ACA individual marketplace is experiencing record‑breaking competition and enrollment. Self‑funded plans are surging, small‑group premiums are driving employers to new coverage models, and major policy shifts in 2025 could redefine affordability for millions. This data‑driven Peterson‑KFF analysis breaks down the trends every insurance, finance, and business professional needs to understand as the industry enters a transformative new era.
Sarasota County is inching closer to approving Winchester Ranch, a massive 8,999‑home community planned for more than 3,100 acres in North Port. With a 7‑1 vote from the Planning Commission and a final decision expected in early 2026, the project could become one of Southwest Florida’s largest developments in decades—bringing new housing, commercial space, and industry while raising fresh questions about growth, the environment, and the region’s rapidly evolving real estate market.
Lument Finance Trust has closed a major $663.8 million commercial real estate CLO, marking one of the standout CRE finance deals of 2025. The transaction, LMNT 2025-FL3, features a strong reinvestment period, non‑recourse and non‑mark‑to‑market financing, and a diversified pool of 32 loans tied to 49 properties nationwide. With J.P. Morgan leading the structuring and more than $585 million placed in investment‑grade securities, the deal highlights renewed stability in transitional CRE debt—making it a development real estate and finance professionals will want to watch closely.
Walmart has partnered with Alquist 3D to roll out the nation’s first large‑scale wave of 3D‑printed commercial buildings, signaling a major shift in how future retail and industrial spaces will be constructed. After completing an 8,000‑square‑foot 3D‑printed expansion in Tennessee—the largest of its kind—the company is moving forward with over a dozen new projects nationwide, accelerating a tech‑driven transformation in commercial real estate.
Citizens Property Insurance Corp. is recommending statewide rate reductions for 2026—the first proposed decrease in more than a decade. Most Citizens policyholders could see an average 11.5% drop, reflecting recent insurance‑market reforms that have stabilized Florida’s turbulent property sector. With hundreds of thousands of policies moving back to private insurers and state‑backed Citizens shrinking to record‑low enrollment, real estate and insurance professionals should prepare for how lower premiums may influence affordability, buyer confidence, and market activity heading into 2026.
